1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 56; p. S549
Main Authors: Llovet, J.M, Decaens, T, Raoul, J.-L, Boucher, E, Kudo, M, Chang, C, Kang, Y.-K, Assenat, E, Lim, H.-Y, Boige, V, Mathurin, P, Fartoux, L, Lin, D.-Y, Bruix, J, Poon, R.T, Sherman, M, Blanc, J.-F, Finn, R, Tak, W.-Y, Chao, Y, Ezzeddine, R, Liu, D, Walters, I, Park, J.-W
Format: Journal Article
Language:English
Published: Elsevier B.V 01-04-2012
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(12)61409-3